Replies to post #16066 on Aurinia Pharmaceuticals Inc (AUPH)

[zzaatt]

did the buy out rumor fizzle once again?

No "buy out rumor", no "fizzle"!

The company will be bought out based on the merits of the drug and the growing acceptance by the medical community.

BTW, speaking of expensive drugs: Entyvio infusions cost twenty thousand dollars a pop, and patients get six a year ($120,000 !!!). Takeda predicts $7.5-$9 billion sales per year.

All this scary talk about how expensive Vocl is does not reflect reality. Payers will pay up, they will have to, it's the best drug for the disease and it keeps patients from getting worse and needing even more expensive treatment.